TY - JOUR T1 - SLE patients are not immune to covid-19: importance of sending the right message across JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e23 LP - e23 DO - 10.1136/annrheumdis-2020-217658 VL - 80 IS - 2 AU - Mohit Goyal Y1 - 2021/02/01 UR - http://ard.bmj.com/content/80/2/e23.abstract N2 - In vitro inhibition of the novel coronavirus, SARS-CoV-2, by hydroxychloroquine (HCQ) has triggered further exploration of the clinical efficacy of this drug in covid-19. Rheumatologists all over the world are analysing registries of patients with systemic lupus erythematosus (SLE) and other rheumatic diseases to look at the prevalence of covid-19 in patients who have been on HCQ. On coming across the title, ‘SLE, hydroxychloroquine and no SLE patients with covid-19: a comment’, we read it with interest. The authors say, “There are several thousands of patients with covid-19 worldwide. Nevertheless, there is no case of SLE with covid-19”. There is no mention of any reference or source to the claim. They go on to extrapolate, “Hence, hydroxychloroquine … ER -